CSIMarket
 


Biogen Inc   (BIIB)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Biogen Inc 's Leverage Ratio

BIIB's quarterly Leverage Ratio and Total Liabilities, Equity growth




BIIB Leverage Ratio (Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
(Dec 31 2019)
IV. Quarter
Y / Y Equity Change -19.89 % -23.21 % -12.82 % -9.3 % 2.36 %
Y / Y Total Liabilities Change 3.27 % 8.4 % 6.51 % 7.58 % 10.03 %
Leverage Ratio MRQ 1.3 1.32 1.26 1.08 1.01
Overall Ranking # # # # #
Seq. Equity Change -0.54 % -4.82 % -9.95 % -6.01 % -4.66 %
Seq. Total Liabilities Change -1.81 % -0.19 % 4.65 % 0.7 % 3.06 %



Leverage Ratio forth quarter 2020 Comment
Due to repayements of liabilities of -1.81% Biogen Inc improved Leverage Ratio in forth quarter 2020 to 1.3, above company's average Leverage Ratio.

Within Biotechnology & Drugs industry in the forth quarter 2020, 12 other companies have achieved lower Leverage Ratio than Biogen Inc . While total ranking remained unchanged compare to previous quarter at no. .

Explain Leverage Ratio?
Who are BIIB Customers?
Leverage Ratio forth quarter 2020 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 13
Healthcare Sector # 49
Overall Market # 323


Leverage Ratio Statistics
High Average Low
1.32 0.57 0.17
(Sep 30 2020)   (Dec. 31, 2005)




Financial Statements
Biogen Inc 's Equity $ 10,686 Millions Visit BIIB's Balance sheet
Biogen Inc 's Total Liabilities $ 13,919 Millions Visit BIIB's Balance sheet
Source of BIIB's Sales Visit BIIB's Sales by Geography




Companies with similar Leverage Ratio in the quarter endingDec 31 2020, within Biotechnology & Drugs Industry Leverage RatioDec 31 2020 MRQ Total LiabilitiesDec 31 2020 MRQ Equity
Navidea Biopharmaceuticals Inc   3.15 $ 6.442  Millions$ 2.047  Millions
Halozyme Therapeutics Inc   2.84 $ 428.877  Millions$ 151.047  Millions
Gilead Sciences Inc   2.57 $ 46,745.000  Millions$ 18,221.000  Millions
Avantor Inc   2.43 $ 6,508.300  Millions$ 2,674.300  Millions
Aptevo Therapeutics Inc   2.23 $ 36.953  Millions$ 16.594  Millions
Aziyo Biologics Inc   2.18 $ 45.346  Millions$ 20.831  Millions
Surgalign Holdings Inc   2.11 $ 51.015  Millions$ 24.170  Millions
Erytech Pharma S a   2.03 $ 60.327  Millions$ 29.724  Millions
Integrated Biopharma Inc  2.00 $ 16.830  Millions$ 8.433  Millions
Neuronetics Inc   1.94 $ 49.449  Millions$ 25.493  Millions
Sunwin Stevia International Inc   1.93 $ 19.269  Millions$ 9.997  Millions
Reynolds Consumer Products Inc   1.92 $ 3,107.000  Millions$ 1,615.000  Millions
Cv Sciences Inc   1.67 $ 18.733  Millions$ 11.212  Millions
Coherus Biosciences inc   1.67 $ 469.198  Millions$ 280.974  Millions
Acorda Therapeutics inc   1.66 $ 394.725  Millions$ 237.955  Millions
Evelo Biosciences Inc   1.59 $ 48.491  Millions$ 30.485  Millions
Eloxx Pharmaceuticals Inc   1.59 $ 16.247  Millions$ 10.230  Millions
Wave Life Sciences Ltd   1.56 $ 129.388  Millions$ 82.778  Millions
Health Discovery Corp  1.49 $ 0.557  Millions$ 0.375  Millions
Cure Pharmaceutical Holding Corp   1.37 $ 29.081  Millions$ 21.279  Millions
Chromadex Corporation  1.34 $ 21.934  Millions$ 16.424  Millions
Biogen Inc   1.30 $ 13,918.600  Millions$ 10,686.100  Millions
Adma Biologics Inc   1.30 $ 114.724  Millions$ 88.249  Millions
Nexien Biopharma Inc   1.28 $ 0.030  Millions$ 0.024  Millions
Obalon Therapeutics Inc  1.28 $ 5.952  Millions$ 4.665  Millions
Merus N v   1.26 $ 128.954  Millions$ 102.263  Millions
Eyenovia Inc   1.22 $ 18.603  Millions$ 15.304  Millions
Royalty Pharma Plc  1.13 $ 11,201.507  Millions$ 9,895.815  Millions
Armata Pharmaceuticals Inc   1.10 $ 20.659  Millions$ 18.857  Millions
Establishment Labs Holdings Inc   1.06 $ 79.504  Millions$ 74.961  Millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CBAN's Profile

Stock Price

CBAN's Financials

Business Description

Fundamentals

Charts & Quotes

CBAN's News

Suppliers

CBAN's Competitors

Customers & Markets

Economic Indicators

CBAN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright Š 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071